Leng, H., & Simon, K. (2019). Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease.
Citazione stile Chigago Style (17a edizione)Leng, H., e K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.
Citatione MLA (9a ed.)Leng, H., e K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.